Nrf1 Antibodies

Santa Cruz Biotechnology provides a broad selection of Nrf1 monoclonal antibodies for research focused on understanding Nuclear factor erythroid 2-related factor 1 (Nrf1) protein functions. Nrf1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Nuclear factor erythroid 2-related factor 1 functions as a transcription factor with a crucial role in cellular responses to oxidative stress and regulation of antioxidant genes. Nrf1 maintains cellular homeostasis and protects cells from damage caused by reactive oxygen species. Research has shown that Nrf1 activity significantly influences various diseases, including neurodegenerative disorders and cancer. Understanding Nrf1's molecular mechanisms and regulatory pathways can provide valuable insights into disease progression and potential therapeutic strategies. Investigating Nrf1's role in oxidative stress response pathways continues to reveal new aspects of cellular defense mechanisms. Current research highlights Nrf1's importance in maintaining cellular health and disease prevention. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of Nrf1's role in human health and disease.